Guggenheim Capital’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,510
| Closed | -$18K | – | 2749 |
|
|
2018
Q1 | $18K | Buy |
2,510
+15
| +0.6% | +$108 | ﹤0.01% | 2751 |
|
|
2017
Q4 | $18K | Sell |
2,495
-311
| -11% | -$2.24K | ﹤0.01% | 2677 |
|
|
2017
Q3 | $23K | Buy |
2,806
+139
| +5% | +$1.14K | ﹤0.01% | 2738 |
|
|
2017
Q2 | $27K | Hold |
2,667
| – | – | ﹤0.01% | 2768 |
|
|
2017
Q1 | $31K | Buy |
2,667
+171
| +7% | +$1.99K | ﹤0.01% | 2754 |
|
|
2016
Q4 | $31K | Hold |
2,496
| – | – | ﹤0.01% | 2823 |
|
|
2016
Q3 | $46K | Buy |
+2,496
| New | +$46K | ﹤0.01% | 2772 |
|
|
2016
Q1 | – | Sell |
-745
| Closed | -$20K | – | 3035 |
|
|
2015
Q4 | $20K | Buy |
745
+62
| +9% | +$1.66K | ﹤0.01% | 2918 |
|
|
2015
Q3 | $31K | Sell |
683
-287
| -30% | -$13K | ﹤0.01% | 2870 |
|
|
2015
Q2 | $31K | Buy |
970
+80
| +9% | +$2.56K | ﹤0.01% | 2978 |
|
|
2015
Q1 | $28K | Buy |
890
+39
| +5% | +$1.23K | ﹤0.01% | 2972 |
|
|
2014
Q4 | $32K | Buy |
851
+75
| +10% | +$2.82K | ﹤0.01% | 2939 |
|
|
2014
Q3 | $20K | Sell |
776
-47
| -6% | -$1.21K | ﹤0.01% | 2921 |
|
|
2014
Q2 | $24K | Buy |
823
+168
| +26% | +$4.9K | ﹤0.01% | 3107 |
|
|
2014
Q1 | $24K | Sell |
655
-71
| -10% | -$2.6K | ﹤0.01% | 3156 |
|
|
2013
Q4 | $30K | Buy |
+726
| New | +$30K | ﹤0.01% | 3037 |
|
|
2013
Q3 | – | Sell |
-559
| Closed | -$30K | – | 3102 |
|
|
2013
Q2 | $30K | Buy |
+559
| New | +$30K | ﹤0.01% | 2868 |
|